Do analysts prefer ACB or CRON?

Cronos Group has a consensus price target of $2.30, indicating a potential downside of 30.51%. Given Cronos Group's higher possible upside, analysts clearly believe Cronos Group is more favorable than Aurora Cannabis. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50 Cronos Group 0 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.40

Does the media refer more to ACB or CRON?

In the previous week, Aurora Cannabis had 7 more articles in the media than Cronos Group. MarketBeat recorded 11 mentions for Aurora Cannabis and 4 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.34 beat Aurora Cannabis' score of 0.25 indicating that Cronos Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 3 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Cronos Group 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer CGC or CRON?

Cronos Group has a consensus price target of $2.30, suggesting a potential downside of 30.51%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts plainly believe Cronos Group is more favorable than Canopy Growth. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Canopy Growth 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 Cronos Group 0 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.40

Does the media refer more to CGC or CRON?

In the previous week, Canopy Growth had 1 more articles in the media than Cronos Group. MarketBeat recorded 5 mentions for Canopy Growth and 4 mentions for Cronos Group. Canopy Growth's average media sentiment score of 0.82 beat Cronos Group's score of 0.34 indicating that Canopy Growth is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Canopy Growth 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cronos Group 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer OGI or CRON?

Cronos Group has a consensus price target of $2.30, indicating a potential downside of 30.51%. Given Cronos Group's stronger consensus rating and higher probable upside, analysts plainly believe Cronos Group is more favorable than Organigram Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Cronos Group 0 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.40

Does the media favor OGI or CRON?

In the previous week, Cronos Group had 3 more articles in the media than Organigram Global. MarketBeat recorded 4 mentions for Cronos Group and 1 mentions for Organigram Global. Cronos Group's average media sentiment score of 0.34 beat Organigram Global's score of 0.16 indicating that Cronos Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Organigram Global 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cronos Group 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger earnings and valuation, CRON or SNDL?

Cronos Group has higher earnings, but lower revenue than SNDL. SNDL is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cronos Group $146.59M 8.37 -$9.45M $0.20 16.55 SNDL $677.32M 0.52 -$11.29M -$0.06 N/A

Is CRON or SNDL more profitable?

Cronos Group has a net margin of 39.08% compared to SNDL's net margin of -2.36%. Cronos Group's return on equity of 4.85% beat SNDL's return on equity. Company Net Margins Return on Equity Return on Assets Cronos Group 39.08% 4.85% 4.62% SNDL -2.36% -2.01% -1.67%

Does the media refer more to CRON or TLRY?

In the previous week, Tilray Brands had 16 more articles in the media than Cronos Group. MarketBeat recorded 20 mentions for Tilray Brands and 4 mentions for Cronos Group. Tilray Brands' average media sentiment score of 0.63 beat Cronos Group's score of 0.34 indicating that Tilray Brands is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cronos Group 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Tilray Brands 8 Very Positive mention(s) 6 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Cronos Group (CRON) Competitors

$3.31 +0.09 (+2.80%)

As of 08/21/2026 04:00 PM Eastern

Compare

CRON vs. ACB, CGC, OGI, SNDL, and TLRY

Should you buy Cronos Group stock or one of its competitors? Cronos Group's main competitors and comparable companies include Aurora Cannabis (ACB), Canopy Growth (CGC), Organigram Global (OGI), SNDL (SNDL), and Tilray Brands (TLRY). Companies are selected based on similarities in market, industry, and size.

How does Cronos Group compare to Aurora Cannabis?

Aurora Cannabis (NASDAQ:ACB) and Cronos Group (NASDAQ:CRON) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

Cronos Group has a consensus price target of $2.30, indicating a potential downside of 30.51%. Given Cronos Group's higher possible upside, analysts clearly believe Cronos Group is more favorable than Aurora Cannabis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Cronos Group	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40

Aurora Cannabis has a beta of 0.58, meaning that its share price is 42% less volatile than the broader market. Comparatively, Cronos Group has a beta of 0.9, meaning that its share price is 10% less volatile than the broader market.

Cronos Group has a net margin of 39.08% compared to Aurora Cannabis' net margin of -32.26%. Cronos Group's return on equity of 4.85% beat Aurora Cannabis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-32.26%	4.37%	3.45%
Cronos Group	39.08%	4.85%	4.62%

47.6% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 8.7% of Cronos Group shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by company insiders. Comparatively, 7.8% of Cronos Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Cronos Group has lower revenue, but higher earnings than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	$247.82M	1.03	-$88.13M	-$1.41	N/A
Cronos Group	$146.59M	8.37	-$9.45M	$0.20	16.55

In the previous week, Aurora Cannabis had 7 more articles in the media than Cronos Group. MarketBeat recorded 11 mentions for Aurora Cannabis and 4 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.34 beat Aurora Cannabis' score of 0.25 indicating that Cronos Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aurora Cannabis	3 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cronos Group	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Cronos Group beats Aurora Cannabis on 12 of the 17 factors compared between the two stocks.

How does Cronos Group compare to Canopy Growth?

Canopy Growth (NASDAQ:CGC) and Cronos Group (NASDAQ:CRON) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends, media sentiment and earnings.

Cronos Group has lower revenue, but higher earnings than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	$251.01M	1.88	-$190.29M	-$0.45	N/A
Cronos Group	$146.59M	8.37	-$9.45M	$0.20	16.55

In the previous week, Canopy Growth had 1 more articles in the media than Cronos Group. MarketBeat recorded 5 mentions for Canopy Growth and 4 mentions for Cronos Group. Canopy Growth's average media sentiment score of 0.82 beat Cronos Group's score of 0.34 indicating that Canopy Growth is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Canopy Growth	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cronos Group	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Cronos Group has a consensus price target of $2.30, suggesting a potential downside of 30.51%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts plainly believe Cronos Group is more favorable than Canopy Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Cronos Group	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40

Cronos Group has a net margin of 39.08% compared to Canopy Growth's net margin of -65.33%. Cronos Group's return on equity of 4.85% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	-65.33%	-21.91%	-14.34%
Cronos Group	39.08%	4.85%	4.62%

Canopy Growth has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market. Comparatively, Cronos Group has a beta of 0.9, meaning that its stock price is 10% less volatile than the broader market.

3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 0.4% of Canopy Growth shares are held by company insiders. Comparatively, 7.8% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Cronos Group beats Canopy Growth on 12 of the 15 factors compared between the two stocks.

How does Cronos Group compare to Organigram Global?

Organigram Global (NASDAQ:OGI) and Cronos Group (NASDAQ:CRON) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, valuation, profitability, analyst recommendations, risk, dividends and earnings.

34.6% of Organigram Global shares are owned by institutional investors. Comparatively, 8.7% of Cronos Group shares are owned by institutional investors. 0.1% of Organigram Global shares are owned by company insiders. Comparatively, 7.8% of Cronos Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Organigram Global has a beta of 1.46, suggesting that its stock price is 46% more volatile than the broader market. Comparatively, Cronos Group has a beta of 0.9, suggesting that its stock price is 10% less volatile than the broader market.

Cronos Group has lower revenue, but higher earnings than Organigram Global. Organigram Global is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram Global	$185.07M	0.95	-$17.70M	$0.46	2.72
Cronos Group	$146.59M	8.37	-$9.45M	$0.20	16.55

In the previous week, Cronos Group had 3 more articles in the media than Organigram Global. MarketBeat recorded 4 mentions for Cronos Group and 1 mentions for Organigram Global. Cronos Group's average media sentiment score of 0.34 beat Organigram Global's score of 0.16 indicating that Cronos Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Organigram Global	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cronos Group	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Cronos Group has a net margin of 39.08% compared to Organigram Global's net margin of 28.14%. Cronos Group's return on equity of 4.85% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Organigram Global	28.14%	-13.39%	-8.67%
Cronos Group	39.08%	4.85%	4.62%

Cronos Group has a consensus price target of $2.30, indicating a potential downside of 30.51%. Given Cronos Group's stronger consensus rating and higher probable upside, analysts plainly believe Cronos Group is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Cronos Group	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Cronos Group beats Organigram Global on 11 of the 15 factors compared between the two stocks.

How does Cronos Group compare to SNDL?

Cronos Group (NASDAQ:CRON) and SNDL (NASDAQ:SNDL) are related small-cap companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, institutional ownership, risk and profitability.

Cronos Group has higher earnings, but lower revenue than SNDL. SNDL is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$146.59M	8.37	-$9.45M	$0.20	16.55
SNDL	$677.32M	0.52	-$11.29M	-$0.06	N/A

In the previous week, Cronos Group had 4 more articles in the media than SNDL. MarketBeat recorded 4 mentions for Cronos Group and 0 mentions for SNDL. SNDL's average media sentiment score of 0.45 beat Cronos Group's score of 0.34 indicating that SNDL is being referred to more favorably in the news media.

Company	Overall Sentiment
Cronos Group	Neutral
SNDL	Neutral

8.7% of Cronos Group shares are owned by institutional investors. 7.8% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Cronos Group currently has a consensus target price of $2.30, indicating a potential downside of 30.51%. SNDL has a consensus target price of $5.00, indicating a potential upside of 264.96%. Given SNDL's higher possible upside, analysts plainly believe SNDL is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40
SNDL	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Cronos Group has a beta of 0.9, indicating that its share price is 10% less volatile than the broader market. Comparatively, SNDL has a beta of 0.93, indicating that its share price is 7% less volatile than the broader market.

Cronos Group has a net margin of 39.08% compared to SNDL's net margin of -2.36%. Cronos Group's return on equity of 4.85% beat SNDL's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	39.08%	4.85%	4.62%
SNDL	-2.36%	-2.01%	-1.67%

Summary

Cronos Group beats SNDL on 12 of the 16 factors compared between the two stocks.

How does Cronos Group compare to Tilray Brands?

Cronos Group (NASDAQ:CRON) and Tilray Brands (NASDAQ:TLRY) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.

8.7% of Cronos Group shares are held by institutional investors. Comparatively, 9.4% of Tilray Brands shares are held by institutional investors. 7.8% of Cronos Group shares are held by insiders. Comparatively, 0.8% of Tilray Brands shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Cronos Group has a net margin of 39.08% compared to Tilray Brands' net margin of -13.11%. Cronos Group's return on equity of 4.85% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	39.08%	4.85%	4.62%
Tilray Brands	-13.11%	-7.76%	-5.59%

Cronos Group has a beta of 0.9, suggesting that its share price is 10% less volatile than the broader market. Comparatively, Tilray Brands has a beta of 1.9, suggesting that its share price is 90% more volatile than the broader market.

In the previous week, Tilray Brands had 16 more articles in the media than Cronos Group. MarketBeat recorded 20 mentions for Tilray Brands and 4 mentions for Cronos Group. Tilray Brands' average media sentiment score of 0.63 beat Cronos Group's score of 0.34 indicating that Tilray Brands is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Tilray Brands	8 Very Positive mention(s)	6 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cronos Group currently has a consensus target price of $2.30, suggesting a potential downside of 30.51%. Tilray Brands has a consensus target price of $11.00, suggesting a potential upside of 127.27%. Given Tilray Brands' stronger consensus rating and higher probable upside, analysts plainly believe Tilray Brands is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40
Tilray Brands	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.50

Cronos Group has higher earnings, but lower revenue than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$146.59M	8.37	-$9.45M	$0.20	16.55
Tilray Brands	$915.45M	0.72	-$121.40M	-$1.08	N/A

Summary

Tilray Brands beats Cronos Group on 9 of the 17 factors compared between the two stocks.

Get Cronos Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CRON vs. The Competition

Export

Metric	Cronos Group	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.23B	$12.57B	$7.37B	$12.85B
Dividend Yield	N/A	2.61%	2.53%	11.08%
P/E Ratio	16.55	789.80	272.60	24.25
Price / Sales	8.37	764.53	624.33	101.47
Price / Cash	264.02	96.77	78.62	53.99
Price / Book	1.10	11.89	13.05	6.20
Net Income	-$9.45M	$2.81B	$3.47B	$348.59M
7 Day Performance	5.41%	1.77%	2.09%	0.08%
1 Month Performance	20.80%	3.85%	6.64%	3.88%
1 Year Performance	27.31%	6.56%	25.02%	16.98%

Cronos Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count
CRON Cronos Group	1.5283 of 5 stars	$3.31 +2.8%	$2.30 -30.5%	+27.3%	$1.23B	$146.59M	16.55	450
ACB Aurora Cannabis	1.4449 of 5 stars	$3.60 -2.2%	N/A	-21.0%	$238.62M	$314.07M	N/A	1,028
CGC Canopy Growth	0.8863 of 5 stars	$1.00 -2.0%	N/A	-17.3%	$457.39M	$251.01M	N/A	1,128
OGI Organigram Global	1.4826 of 5 stars	$1.23 -0.4%	N/A	-21.9%	$173.40M	$185.07M	2.66	1,139
SNDL SNDL	2.9206 of 5 stars	$1.23 -2.4%	$5.00 +306.5%	-39.1%	$324.32M	$677.32M	N/A	2,751

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CRON) was last updated on 8/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cronos Group (CRON) Competitors

CRON vs. ACB, CGC, OGI, SNDL, and TLRY

How does Cronos Group compare to Aurora Cannabis?

Summary

How does Cronos Group compare to Canopy Growth?

Summary

How does Cronos Group compare to Organigram Global?

Summary

How does Cronos Group compare to SNDL?

Summary

How does Cronos Group compare to Tilray Brands?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRON vs. The Competition

Cronos Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cronos Group (CRON) Competitors

CRON vs. ACB, CGC, OGI, SNDL, and TLRY

How does Cronos Group compare to Aurora Cannabis?

Do analysts prefer ACB or CRON?

Which has more risk and volatility, ACB or CRON?

Is ACB or CRON more profitable?

Do institutionals & insiders believe in ACB or CRON?

Which has higher earnings and valuation, ACB or CRON?

Does the media refer more to ACB or CRON?

Summary

How does Cronos Group compare to Canopy Growth?

Which has stronger valuation & earnings, CGC or CRON?

Does the media refer more to CGC or CRON?

Do analysts prefer CGC or CRON?

Is CGC or CRON more profitable?

Which has more risk & volatility, CGC or CRON?

Do insiders and institutionals have more ownership in CGC or CRON?

Summary

How does Cronos Group compare to Organigram Global?

Do institutionals and insiders have more ownership in OGI or CRON?

Which has more volatility and risk, OGI or CRON?

Which has stronger valuation and earnings, OGI or CRON?

Does the media favor OGI or CRON?

Is OGI or CRON more profitable?

Do analysts prefer OGI or CRON?

Summary

How does Cronos Group compare to SNDL?

Which has stronger earnings and valuation, CRON or SNDL?

Does the media refer more to CRON or SNDL?

Do institutionals and insiders believe in CRON or SNDL?

Do analysts recommend CRON or SNDL?

Which has more risk & volatility, CRON or SNDL?

Is CRON or SNDL more profitable?

Summary

How does Cronos Group compare to Tilray Brands?

Do insiders & institutionals hold more shares of CRON or TLRY?

Is CRON or TLRY more profitable?

Which has more volatility & risk, CRON or TLRY?

Does the media refer more to CRON or TLRY?

Do analysts rate CRON or TLRY?

Which has better earnings and valuation, CRON or TLRY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRON vs. The Competition

Cronos Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools